# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ten of the Dow Jones Industrial Average stocks were up double digit percentage in the first half of 2024. A look at the best an...
Merck secures exclusive global rights to develop and commercialize opevesostat (MK-5684/ODM-208) for hormone-dependent cancers....
The CDC's Advisory Committee on Immunization Practices recommends Merck's Capvaxive for adults 65+ and certain at-risk ...
, European Commission's Decision Is Expected In Q3
- Bloomberg
- Reuters